Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Amgen
National Institutes of Health Clinical Center (CC)
Vividion Therapeutics, Inc.
QuantumLeap Healthcare Collaborative
UNICANCER
Weill Medical College of Cornell University
National University Hospital, Singapore
Nurix Therapeutics, Inc.
Shandong Cancer Hospital and Institute
University of California, San Diego
The First Affiliated Hospital of Guangzhou Medical University
Fudan University
Shandong University